CTSN Embolic Protection Trial
842
about 3.5 years
60+
24 sites in AR, CA, GA +14
What this study is about
Researchers are testing a new device called CardioGard to protect against blood clots in patients undergoing valve surgery. The trial will compare the CardioGard device to a standard cannula, which is a tube used during surgery. It will last for 12 months after the surgery.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use CardioGard Embolic Protection Cannula
- 2.Use Standard Aortic Cannula
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Secondary: All-cause mortality, Length of Index Hospitalization, Montreal Cognitive Assessment (MoCA) Score
therapeutic
Neurology, Renal, Cardiology / Heart